Beginner’s Mind Podcast Notes by Christian Soschner
Beginner's Mind
#41: The 7 Key Success Factors of Building Great Life Science Companies.
0:00
-1:05:42

#41: The 7 Key Success Factors of Building Great Life Science Companies.

with Christoph Lengauer from Third Rock Ventures

This episode will discuss what it takes to build companies that develop novel therapies, vaccines, and diagnostics in the pharma industry.

Since the pandemic, everybody has become familiar with the critical elements of pharma product development.

But let’s take a closer look into the value chain of the industry.

What does it take to pick up a technology and bring it to patients?

Questions we will discuss:

Some questions we will focus on:

  • What strategic approaches do exist for life science companies?

  • How important is the team in developing a company to an IPO?

  • Where can scientists find help when they want to start a company?

About Christoph Lengauer (from Third Rock Ventures)

The most powerful thing about being a part of this industry is having the opportunity to improve the lives of patients and their families.”

Christoph loves the ideation of new company concepts and focuses on the formation, development, and strategy of our portfolio companies. He is an accomplished scientist and drug hunter with the ability to translate that knowledge, insight, and expertise into compelling business strategies. Christoph has contributed to the discovery and development of eight FDA-approved medicines.

Christoph is dedicated to making a dramatic difference in patients’ lives. He is enthusiastic about Third Rock’s approach to discover, launch and build great companies by focusing on bold ideas that meet at the intersection of science, strategy, business, and medicine. He is especially excited by initiatives at the firm focusing on the early detection of diseases in order to not only treat but cure patients.

By leveraging his experiences and networks from academia, pharma, and biotech, he hopes to continue building great teams that help young companies succeed with this important mission.

Over his career, Christoph has received numerous awards, including the Novartis Oncology’s President’s Award for Top Innovator, and has been elected to membership in the Johns Hopkins Society of Scholars.

About Third Rock Ventures

We discover, launch, and build great companies based on bold ideas that meet at the intersection of science, strategy, business, and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives.

THE THIRD ROCK TEAM

Our team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy, and plan needed to succeed.

A FORMULA FOR INNOVATION

We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence. We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices, and diagnostics. By creating value for patients, we create value for our investors.

Link to the Video of the Recording:
YouTube

Speaker:
Christoph Lengauer
Christian Soschner

Organizations:
CS Life Science Invest
Third Rock Ventures

Available on All Podcast Platforms after May 27. Guaranteed Ad-Free only here.


Community Partner:

These companies make the community, this newsletter, and the LSG2G Podcast possible, so go check them out and thank them for their support!

Partner Links


You are receiving the LSG2G-Letter because you either signed up or attended one of the events organized by LSG2G. Feel free to unsubscribe if you aren’t finding this valuable.

Nothing in this email is intended to serve as financial or investment advice. Do your own research.

0 Comments
Beginner’s Mind Podcast Notes by Christian Soschner
Beginner's Mind
Conversations about Life Science, Science, Business, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Join the podcast community: https://lsg2g.substack.com/subscribe